Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review

Infection with the hepatitis B virus (HBV) is one of the leading global public health issues. Over 250 million people worldwide have chronic HBV infection, out of which roughly 65 million are women in their reproductive age. The most common route of passing the infection in areas of high endemicity...

Full description

Saved in:
Bibliographic Details
Main Authors: Iulia Baciu, Dalila-Ana Domuncu, Tiberiu Domuncu, AncaMarina Ciobanu, Theodor Voiosu, Gheorghe Peltecu, AncaMaria Panaitescu
Format: Article
Language:English
Published: IMR Press 2021-02-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/48/1/10.31083/j.ceog.2021.01.2240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850159006761353216
author Iulia Baciu
Dalila-Ana Domuncu
Tiberiu Domuncu
AncaMarina Ciobanu
Theodor Voiosu
Gheorghe Peltecu
AncaMaria Panaitescu
author_facet Iulia Baciu
Dalila-Ana Domuncu
Tiberiu Domuncu
AncaMarina Ciobanu
Theodor Voiosu
Gheorghe Peltecu
AncaMaria Panaitescu
author_sort Iulia Baciu
collection DOAJ
description Infection with the hepatitis B virus (HBV) is one of the leading global public health issues. Over 250 million people worldwide have chronic HBV infection, out of which roughly 65 million are women in their reproductive age. The most common route of passing the infection in areas of high endemicity is by mother-to-child transmission (MTCT). In children the infection may still occur despite adequate immunoprophylaxis, however, antiviral medication, such as Tenofovir disoproxil fumarate (TDF), may be helpful in reducing the risk of MTCT. A literature review was conducted concerning TDF’s role in preventing MTCT and its safety in pregnancy. Studies were identified by researching various databases up to 2020 for variations of the following sentence: “Tenofovir disoproxil fumarate and Lamivudine and Telbivudine and Entecavir and pregnancy and transmission and safety and HBV”. Prenatal and perinatal adequate management of maternal HBV infection is of utmost importance, with focus on prevention of MTCT as the key strategy to reduce the global HBV infection burden. This review discusses the most up-to-date evidence from a multidisciplinary perspective of using TDF to reduce MTCT of HBV infection as well as its safety profile for pregnant women.
format Article
id doaj-art-66fe5599df664f9791496810d313a0a9
institution OA Journals
issn 0390-6663
language English
publishDate 2021-02-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-66fe5599df664f9791496810d313a0a92025-08-20T02:23:43ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632021-02-0148191810.31083/j.ceog.2021.01.2240S0390-6663(21)00038-5Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature reviewIulia Baciu0Dalila-Ana Domuncu1Tiberiu Domuncu2AncaMarina Ciobanu3Theodor Voiosu4Gheorghe Peltecu5AncaMaria Panaitescu6Obstetrics-Gynecology, Filantropia Clinical Hospital, 010082 Bucharest, RomaniaIntensive Care Department, National Institute for Infectious Diseases “Prof. dr. Matei Balș”, 010082 Bucharest, RomaniaDepartment of Nephrology, “Dr. Carol Davila” Clinical Nephrology Hospital, 010082 Bucharest, RomaniaObstetrics-Gynecology, Filantropia Clinical Hospital, 010082 Bucharest, RomaniaDepartment of Gastroneterology, Colentina Hospital, 010082 Bucharest, RomaniaObstetrics-Gynecology, Filantropia Clinical Hospital, 010082 Bucharest, RomaniaObstetrics-Gynecology, Filantropia Clinical Hospital, 010082 Bucharest, RomaniaInfection with the hepatitis B virus (HBV) is one of the leading global public health issues. Over 250 million people worldwide have chronic HBV infection, out of which roughly 65 million are women in their reproductive age. The most common route of passing the infection in areas of high endemicity is by mother-to-child transmission (MTCT). In children the infection may still occur despite adequate immunoprophylaxis, however, antiviral medication, such as Tenofovir disoproxil fumarate (TDF), may be helpful in reducing the risk of MTCT. A literature review was conducted concerning TDF’s role in preventing MTCT and its safety in pregnancy. Studies were identified by researching various databases up to 2020 for variations of the following sentence: “Tenofovir disoproxil fumarate and Lamivudine and Telbivudine and Entecavir and pregnancy and transmission and safety and HBV”. Prenatal and perinatal adequate management of maternal HBV infection is of utmost importance, with focus on prevention of MTCT as the key strategy to reduce the global HBV infection burden. This review discusses the most up-to-date evidence from a multidisciplinary perspective of using TDF to reduce MTCT of HBV infection as well as its safety profile for pregnant women.https://www.imrpress.com/journal/CEOG/48/1/10.31083/j.ceog.2021.01.2240tenofovirhepatitis btransmissionmother to childfetal infectionprevention
spellingShingle Iulia Baciu
Dalila-Ana Domuncu
Tiberiu Domuncu
AncaMarina Ciobanu
Theodor Voiosu
Gheorghe Peltecu
AncaMaria Panaitescu
Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
Clinical and Experimental Obstetrics & Gynecology
tenofovir
hepatitis b
transmission
mother to child
fetal infection
prevention
title Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
title_full Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
title_fullStr Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
title_full_unstemmed Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
title_short Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
title_sort tenofovir disoproxil fumarate for preventing mother to child transmission of hepatitis b a literature review
topic tenofovir
hepatitis b
transmission
mother to child
fetal infection
prevention
url https://www.imrpress.com/journal/CEOG/48/1/10.31083/j.ceog.2021.01.2240
work_keys_str_mv AT iuliabaciu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview
AT dalilaanadomuncu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview
AT tiberiudomuncu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview
AT ancamarinaciobanu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview
AT theodorvoiosu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview
AT gheorghepeltecu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview
AT ancamariapanaitescu tenofovirdisoproxilfumarateforpreventingmothertochildtransmissionofhepatitisbaliteraturereview